VEGFA and neoplasm: The ambiguous processes inducing resistance remain to be clarified but include tumours exploiting non-VEGF pro-angiogenic pathways, obtaining blood supply via non-angiogenic methods such as vasculogenic mimicry and ineffective utilisation of the normalisation window during treatment.